Curbing Drug Price Markups
2.3 Social Justice, The Hindu, 2026-10-01
The Supreme Court flagged gaps between the price to retailer (PTR) and maximum retail price (MRP) of drugs, including cancer drugs, up to 1,000%. The 2013 Drug (Prices Control) Order caps final prices of scheduled drugs but not hospital markups. In 2019, the National Pharmaceutical Pricing Authority capped trade margins of 42 non-schedule anti-cancer drugs at 30%, and prices of 526 brands dropped by up to 91%. A regressive margin is suggested alongside a fixed markup.